News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,068 Results
Type
Article (87972)
Company Profile (825)
Press Release (781254)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233267)
Career Advice (4147)
Deals (39880)
Drug Delivery (151)
Drug Development (91418)
Employer Resources (205)
FDA (18388)
Job Trends (17428)
News (397922)
Policy (39969)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (146)
Alliances (56981)
ALS (180)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (346)
Approvals (18570)
Artificial intelligence (624)
Autoimmune disease (160)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (661)
Cancer (5020)
Cardiovascular disease (442)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (825)
Cervical cancer (37)
Clinical research (77009)
Collaboration (1804)
Company closure (5)
Compensation (1150)
Complete response letters (70)
COVID-19 (2992)
CRISPR (99)
C-suite (857)
Cystic fibrosis (154)
Data (6249)
Decentralized trials (2)
Denatured (72)
Depression (150)
Diabetes (531)
Diagnostics (7223)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (301)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100131)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135060)
Executive appointments (1031)
FDA (21560)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1553)
Gene editing (215)
Generative AI (64)
Gene therapy (669)
GLP-1 (1122)
Government (5438)
Grass and pollen (8)
Guidances (385)
Healthcare (20944)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (290)
Immuno-oncology (58)
Indications (94)
Infectious disease (3278)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (245)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (67)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (15)
Lung cancer (678)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (846)
MASH (172)
Medical device (15023)
Medtech (15075)
Mergers & acquisitions (22983)
Metabolic disorders (1389)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (353)
Neuropsychiatric disorders (96)
Neuroscience (3102)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5111)
Now hiring (66)
Obesity (672)
Opinion (335)
Ovarian cancer (166)
Pain (206)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (504)
Patient recruitment (477)
Peanut (60)
People (66900)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33417)
Phase III (25182)
Pipeline (4981)
Policy (335)
Postmarket research (3554)
Preclinical (10691)
Press Release (72)
Prostate cancer (243)
Psychedelics (53)
Radiopharmaceuticals (301)
Rare diseases (890)
Real estate (7439)
Recruiting (80)
Regulatory (28994)
Reports (67)
Research institute (2724)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (122)
Vaccines (1144)
Venture capital (95)
Weight loss (462)
Women's health (85)
Worklife (21)
Date
Today (168)
Last 7 days (476)
Last 30 days (2420)
Last 365 days (33012)
2026 (2378)
2025 (33230)
2024 (38141)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51552)
Australia (9052)
California (11506)
Canada (3303)
China (1162)
Colorado (488)
Connecticut (499)
Delaware (344)
Europe (118428)
Florida (1683)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (962)
India (67)
Indiana (541)
Iowa (24)
Japan (426)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1453)
Massachusetts (8476)
Michigan (356)
Minnesota (663)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3097)
New Mexico (33)
New York (3040)
North Carolina (1608)
North Dakota (10)
Northern California (5497)
Ohio (352)
Oklahoma (22)
Oregon (54)
Pennsylvania (2306)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4442)
Tennessee (176)
Texas (1813)
United States (41528)
Utah (345)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (970)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 870,068 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
Eikon, Veradermics, Announce IPO Targets as Cautious Optimism Propels Biotech Market
Cancer-focused Eikon Therapeutics is seeking $273.5 million in its bid to trade on the Nasdaq, while hair growth specialist Veradermics is looking for $181.1 million in its foray onto the New York Stock Exchange.
January 29, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
·
7 min read
Press Releases
UTMD Reports Year 2025 and Fourth Quarter Financial Performance
January 29, 2026
·
25 min read
Press Releases
Encision Deregisters Common Stock
January 29, 2026
·
2 min read
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
Press Releases
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
January 29, 2026
·
1 min read
Press Releases
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
January 29, 2026
·
4 min read
Press Releases
Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board
January 29, 2026
·
7 min read
Press Releases
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
January 29, 2026
·
1 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
January 29, 2026
·
1 min read
1 of 87,007
Next
